During clinical trials, histology continues to play a vital role in monitoring the effects of the drug on human tissues. The EMA evaluates histological data from biopsies and other tissue samples to:
Monitor any adverse effects on tissues and organs. Assess the therapeutic impact of the drug on diseased tissues. Ensure the overall safety and efficacy of the drug for human use.
